Clinical trial
Bone Properties in Hypoparathyroidism: Effects of PTH
NCT00473265 · John P. Bilezikian, Other · Completed
Key facts
| NCT number | NCT00473265 |
|---|---|
| Title | Bone Properties in Hypoparathyroidism: Effects of PTH |
| Official title | Bone Properties in Hypoparathyroidism: Effects of PTH |
| Lead sponsor | John P. Bilezikian, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hypoparathyroidism |
| Intervention type | Drug |
| Interventions | PTH |
| Enrollment | 68 |
| Start date | May 1, 2004 |
| Primary completion | Jan 1, 2011 |
| Completion | Jun 1, 2014 |
| First posted | May 15, 2007 |
| Last update posted | Jul 16, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: